astriatx.com Open in urlscan Pro
35.208.74.80  Public Scan

Form analysis
0 forms found in the DOM

Text Content

This website uses cookies to improve website functionality. By using this
website, you consent to our use of cookies. You may delete or block cookies by
accessing your preferences. For more information, please see our Privacy Policy
and our Terms of Use.
Okay

✕
For Patients
ALPHA-STAR Trial Patient Stories Newsletters Resources
Our Science
About HAE STAR-0215 Scientific Presentations and Publications
About Us
Mission & Values Our Team Join Us Partner with Us
Contact Us
For Investors
Press Releases Events & Presentations SEC Filings Certain Tax Forms Corporate
Governance Stock Information Analyst Coverage Investor Resources Investors FAQs
Contact IR Email Alerts


PATIENTS FIRST
PEOPLE ALWAYS

WITH PATIENTS AS OUR GUIDING STARS, ASTRIA THERAPEUTICS’ DEDICATED AND
PASSIONATE TEAM IS DEVOTED TO BRINGING LIFE-CHANGING THERAPIES TO PATIENTS AND
FAMILIES IMPACTED BY HAE AND RARE AND NICHE ALLERGIC AND IMMUNOLOGICAL DISEASES.

Our Lead Program STAR-0215



WHY ASTRIA

Our name comes from the Greek word for star, and at Astria, patients are the
stars that guide our journey.

Their stories inspire us, their successes energize us, and their challenges give
us purpose.

Astria’s mission is propelled by the voice of the patient.

WE LISTEN TO THE COMMUNITIES OF THOSE IMPACTED BY RARE AND NICHE DISEASES, LEARN
FROM AND ARE GUIDED BY THEIR EXPERIENCES.



Our stars illuminate our work, creating an environment of transparency and
openness that allows us to build trust with each other, patient communities,
shareholders, and all of our partners and collaborators.

Our vision is a world where science, passion, and compassion create better
todays and more tomorrows.

We are seeking new talented team members who are also compelled by our mission
of bringing hope with life-changing therapies to patients and families.





OUR PATIENTS

We at Astria listen to the voices of HAE patient communities to better
understand their needs, which guide all that we do.

Our goal is to develop treatments that bring meaningful changes to patients’
lives by pushing the boundaries of what is possible.


VIEW JASMINE’S STORY





FEATURED NEWS & EVENTS

December 19, 2022

Astria Therapeutics Announces Closing of Underwritten Offering and Full Exercise
of Underwriters’ Option to Purchase Additional Shares

December 15, 2022

Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of
Common Stock

December 15, 2022

Astria Therapeutics Announces Positive Preliminary Results from the Phase 1a
Clinical Trial of STAR-0215 in Healthy Subjects

Positive Preliminary Results from Phase 1a Trial

Read the Press Release

--------------------------------------------------------------------------------

Watch the Webcast


ASTRIA THERAPEUTICS ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM THE PHASE 1A
CLINICAL


TRIAL OF STAR-0215 IN HEALTHY SUBJECTS

Read the Press Release Watch the Webcast


FOR PATIENTS

ALPHA-STAR Trial

Patient Stories

Newsletters

Resources

OUR SCIENCE

About HAE

STAR-0215

Scientific Presentations and Publications

ABOUT US

Mission & Values

Join Us

Our Team

Partner With Us

CONTACT US

FOR INVESTORS




© Copyright 2023 | Astria Therapeutics, Inc.
| Terms of Use | Privacy Statement